Variable | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95%CI | P-value | HR | 95%CI | P-value | |
Sex | ||||||
Male | 1.21 | 0.68–2.16 | 0.508 | – | – | – |
Female | Ref | |||||
Age | 1.03 | 1.01–1.05 | 0.001 | 1.06 | 1.02–1.10 | 0.003 |
BMI (kg/m2) | 0.99 | 0.94–1.03 | 0.497 | – | – | – |
Underlying disease | ||||||
Hypertension | 1.22 | 0.67–2.23 | 0.506 | – | – | – |
Diabetes mellitus | 0.67 | 0.36–1.22 | 0.187 | – | – | – |
Chronic kidney disease | 1.34 | 0.65–2.80 | 0.426 | – | – | – |
Obesity | 0.95 | 0.37–2.41 | 0.908 | – | – | – |
Day of starting dexamethasone treatment | 0.87 | 0.78–0.97 | 0.012 | 0.66 | 0.48–0.91 | 0.11 |
Day from onset of symptoms to starting favipiravir | 0.79 | 0.70–0.90 | < 0.001 | 1.11 | 0.80–1.54 | 0.548 |
Receiving CPT | 0.14 | 0.07–0.31 | < 0.001 | 0.26 | 0.08–0.79 | 0.018 |